Success of ophthalmic pharmaceutical start-up companies
نویسندگان
چکیده
منابع مشابه
Description of Ophthalmic Pharmaceutical and Device Start-Up Companies.
AIMS To describe the number, type and location of ophthalmic companies and their associated product areas and indications. METHODS A retrospective, non-patient-based, observational review of ophthalmic pharmaceutical and device companies with a new product in development. Data was compiled by Internet searches. RESULTS We identified 190 companies currently developing ophthalmic products: 13...
متن کاملChallenges facing ophthalmic start-up companies in developing new devices or medicines.
tudes, the cabin pressure can decrease about 200 mmHg in a few minutes (Dieckert et al. 1986), whereas meteorological alterations of the atmospheric pressure change slower and only in a magnitude of 20–30 mmHg. Nevertheless, in a gas-filled sphere with rigid walls, even a slow decrease in the ambient air pressure would result in an increase in IOP. However, such a model sphere does not reflect ...
متن کاملOpportunistic Adaptation in Start - Up Companies -
It has been proposed that a key success factor for entrepreneurial start-up companies in dynamic industries is their capacity to continuously adapt their business opportunistically. However, the concept of opportunistic adaptation is in need of further development and clarification in order to make it possible to empirically test its usefulness, something that this far has been done only to a l...
متن کاملE - Novation and Start - Up Companies
Author experiences from working jointly and within startups inform this chapter. Emphasizing the importance of employees achieving unprecedented productivity through working collaboratively and supported by flexible roles and social technologies cannot be understated. Startup employees led by the entrepreneur are masters of embracing complexity. This means the startup team understands cause and...
متن کاملValuation of Early Stage High-tech Start-up Companies
Valuating start-ups, especially at early stages, is a challenge given the lack of historical data and many uncertain factors about the future. This article presents a methodology for the valuation of early stage start-ups that we have proven in practice. The risk linked to a start-up is expressed through an individual beta coefficient as important component of the discounting factor within a di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Ophthalmologica
سال: 2017
ISSN: 1755-375X
DOI: 10.1111/aos.13563